These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31550726)

  • 1. Autotaxin Inhibitor Protects from Chronic Allograft Injury in Rat Kidney Allotransplantation.
    Cortinovis M; Aiello S; Mister M; Conde-Knape K; Noris M; Novelli R; Solini S; Rodriguez Ordonez PY; Benigni A; Remuzzi G
    Nephron; 2020; 144(1):38-48. PubMed ID: 31550726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
    Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
    Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of chronic allograft nephropathy.
    Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Allen RD; Chapman JR
    N Engl J Med; 2003 Dec; 349(24):2326-33. PubMed ID: 14668458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chronic renal rejection model with a fully MHC-mismatched rat strain combination under immunosuppressive therapy.
    Hanaoka K; Kawato Y; Kubo K; Nakanishi T; Maeda M; Nakamura K; Hirose J; Noto T; Fukahori H; Fujikawa A; Miyoshi S; Takakura S; Morokata T; Higashi Y
    Transpl Immunol; 2016 Sep; 38():19-26. PubMed ID: 27545900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
    Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
    Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine lysophosphatidic acid signaling activates β-catenin and promotes lung allograft fibrosis.
    Cao P; Aoki Y; Badri L; Walker NM; Manning CM; Lagstein A; Fearon ER; Lama VN
    J Clin Invest; 2017 Apr; 127(4):1517-1530. PubMed ID: 28240604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury.
    Cassis P; Gallon L; Benigni A; Mister M; Pezzotta A; Solini S; Gagliardini E; Cugini D; Abbate M; Aiello S; Rocchetta F; Scudeletti P; Perico N; Noris M; Remuzzi G
    Kidney Int; 2012 May; 81(9):903-18. PubMed ID: 22318420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism.
    Amuchastegui SC; Azzollini N; Mister M; Pezzotta A; Perico N; Remuzzi G
    J Am Soc Nephrol; 1998 Oct; 9(10):1948-55. PubMed ID: 9773797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
    Black KE; Berdyshev E; Bain G; Castelino FV; Shea BS; Probst CK; Fontaine BA; Bronova I; Goulet L; Lagares D; Ahluwalia N; Knipe RS; Natarajan V; Tager AM
    FASEB J; 2016 Jun; 30(6):2435-50. PubMed ID: 27006447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis.
    Baader M; Bretschneider T; Broermann A; Rippmann JF; Stierstorfer B; Kuttruff CA; Mark M
    Br J Pharmacol; 2018 Feb; 175(4):693-707. PubMed ID: 29197066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor antagonism and aldosterone synthesis inhibition do not improve glomerulosclerosis and renal interstitial fibrosis in a model of chronic kidney allograft injury.
    Lahmer T; Hermans R; Schmaderer C; Chang J; Stock K; Lutz J; Heemann U; Baumann M
    Kidney Blood Press Res; 2012; 35(6):561-7. PubMed ID: 22890233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute rejection after kidney transplantation promotes graft fibrosis with elevated adenosine level in rat.
    Li M; Dai Y; Lei J; Tang J; Zhou Y; Xia B; Xia Y; Yin G
    PLoS One; 2017; 12(6):e0180211. PubMed ID: 28651015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
    Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
    Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor inhibition, a novel pathway to prevent chronic allograft injury.
    Rintala JM; Savikko J; Palin N; Rintala SE; Koskinen PK; von Willebrand E
    Transplantation; 2014 Oct; 98(8):821-7. PubMed ID: 25073034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autotaxin inhibitors: a patent review (2012-2016).
    Nikolaou A; Kokotou MG; Limnios D; Psarra A; Kokotos G
    Expert Opin Ther Pat; 2017 Jul; 27(7):815-829. PubMed ID: 28447479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
    Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Tomiya T; Tejima K; Nishikawa T; Arai M; Yanase M; Aoki J; Arai H; Omata M; Fujiwara K; Yatomi Y
    Life Sci; 2007 Sep; 81(12):1009-15. PubMed ID: 17850827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.